Rodolfo San Antonio

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · Journal of the American College of Cardiology · 2019 · 633 citations

Myocardial Energetics, Cardiomyopathy, Heart Failure +8

Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · JACC. Cardiovascular imaging · 2020 · 183 citations

Metabolic Syndrome, Left Ventricular Fibrosis/stiffness, Heart Failure +9

Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘Ablate by-LAW’ single-centre study—a pilot study

Cheryl Terés, David Soto‐Iglesias, Diego Penela et al. · EP Europace · 2021 · 54 citations

Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence

Levio Quinto, Paula Sánchez-Somonte, Francisco Alarcón et al. · Heart Rhythm · 2021 · 43 citations · Full text

Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia

Gustavo Jiménez-Brítez, Xavier Freixa, Eduardo Flores‐Umanzor et al. · Resuscitation · 2017 · 33 citations

Percutaneous Coronary Intervention, Thrombosis, Stent Thrombosis +10